Response to the Remote Clinical Trial System
First written in FY2021-Q3. 1 of 2 entries say "Advanced", first in FY2021. Latest entry: FY2021.
No other company in this theme has enough history to compare yet.
- FY2021AdvancedAnnual report
「For clinical trial operations, measures were taken to comply with a framework enabling clinical trials to be conducted remotely. The U.S. subsidiary responded promptly, allowing it to steadily work through the orders accumulated substantially through the strengthening of its operating structure since the previous fiscal year. Together with the benefits of greater organizational and operational efficiency, this resulted in stable operating profitability from August 2020 onward.」
The U.S. subsidiary responded promptly to the remote clinical trial framework and achieved stable operating profitability from August 2020 onward by working through orders and improving organizational and operational efficiency. - FY2021-Q3First statedAnnual report
「For clinical trial operations, measures were taken to comply with a framework enabling clinical trials to be conducted remotely. As a result of the U.S. subsidiary's prompt response to these measures, it steadily worked through the planned hours for orders accumulated substantially through the strengthening of its operating structure in the previous fiscal year, and it has remained operating-profit positive since August.」
The U.S. subsidiary's prompt response to the framework enabling remote clinical trials, leading to the completion of planned hours for orders and sustained operating profitability from August onward, can be identified for the first time as an independent theme.